Skip to content

Role of Individualized Homoeopathic Medicines in cases of Irritable Bowel Syndrome

Exploring the indications of frequently prescribed individualized homoeopathic medicines in cases of Irritable Bowel Syndrome assessed by Birmingham IBS Symptoms Score in Mehsana district-An Observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097448
Enrollment
40
Registered
2025-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Individualized Homoeopathic Medicine: To observe which frequently prescribed homoeopathic individualized medicines in Mehsana district Potency Decimal Centesimal 50 Millesimal Doses as

Sponsors

Dr Nidhiben Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age groups 18 to 50 who suffering from Irritable Bowel Syndrome Gender- Men women and transgender Confirmed diagnosis of IBS according to Rome IV criteria Consent - participants are willing to provide written informed consent to participate in the study and can fill out the Birmingham IBS symptoms score by themselves

Exclusion criteria

Exclusion criteria: Patients who have received any form of treatment-homoeopathic ayurvedic allopathic or any other alternative therapies for irritable bowel syndrome within past 10 days Abdominal surgery within the last past 6 months History of inflammatory bowel disease celiac disease or other diagnosed gastrointestinal pathology, renal failure, cardiomegaly, any malignancy and uncontrolled diabetes Presence of red flag symptoms suggesting organic disease-rectal bleeding unexplained weight loss more than 5 kg family history of colorectal cancer Patient having severe psychiatric disorder like depression with suicidal tendency schizophrenia bipolar disorder cognitive disorder like dementia

Design outcomes

Primary

MeasureTime frame
By Using Birmingham IBS symptoms scoreTimepoint: Questionnaire will be assessed at 4 week and data will be evaluated at baseline-0 month and the 8 months of treatment

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Nidhiben Patel

Smt A J Savla Homoeopathic Medical College and Research Institute

nisha.mehul.26@gmail.com9974342824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026